{"id":"NCT03325556","sponsor":"ACADIA Pharmaceuticals Inc.","briefTitle":"Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis","officialTitle":"A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-27","primaryCompletion":"2019-07-31","completion":"2019-10-30","firstPosted":"2017-10-30","resultsPosted":"2021-06-21","lastUpdate":"2021-06-21"},"enrollment":392,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dementia-related Psychosis"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Pimavanserin 34 mg","otherNames":[]},{"type":"DRUG","name":"Pimavanserin 20 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Drug - Pimavanserin","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of pimavanserin compared to placebo in preventing relapse of psychotic symptoms in subjects with dementia-related psychosis who responded to 12 weeks of open label pimavanserin treatment.","primaryOutcome":{"measure":"Time From Randomization to Relapse in the Double-blind (DB) Period","timeFrame":"From randomization in the DB period through 26 weeks","effectByArm":[{"arm":"Pimavanserin Double-Blind Period","deltaMin":null,"sd":null},{"arm":"Placebo Double-Blind Period","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0023"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":83,"countries":["United States","Bulgaria","Chile","Czechia","France","Germany","Italy","Poland","Serbia","Slovakia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["34934801","34289275"],"seeAlso":["https://link.springer.com/article/10.14283/jpad.2019.47"]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":392},"commonTop":["Urinary tract infection","Headache"]}}